David McErlane

Articles

The Evolution of Cell & Gene Therapy: Development and Manufacturing Insights and the Role of CDMOs

December 23rd 2024

David McErlane, Group President of Biologics, Catalent, reacts to trends in cell and gene therapy development and manufacturing and comments on Catalent's ESG strategy to support people, the environment, and communities.

Latest Updated Articles

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Published: January 10th 2025 | Updated: January 13th 2025

Cavazzoni Retires as CDER Director

Published: October 11th 2024 | Updated: October 18th 2024

Buy, Sell, Hold: Cell and Gene Therapy - Part 1

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 10th 2024 | Updated: September 18th 2024

CPHI Milan Announces 2024 CPHI Pharma Award Finalists

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

Published: January 28th 2025 | Updated: February 5th 2025

Lantheus Announces Agreement to Acquire Evergreen Theragnostics

Published: June 2nd 2020 | Updated: February 5th 2025

Reducing Risk with Abuse‑Deterrent Formulations

Published: August 21st 2024 | Updated: February 5th 2025

Vial Containment Systems for Gene Therapies

About Us

Advertise

Editorial Info

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777